The subgroup analysis of OS and PFI according to different clinicopathological stages suggested that HCC patients with low BAIAP2L2 expression had better OS and PFI in the Asian, albumin ≥ 3.5 g/dL, N0 and M0 groups. This evidence concerns the gene BAIAP2L2 and hepatocellular carcinoma.